| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
2 companies
Smith Sandford D is a Director at PALI with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 23 sells.
Estimated insider holdings value: $1.9M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 2, 2022 | CYTK Cytokinetics Inc | Director | Sale+OE | 11,369 | $53.97 | $613,584.93 | -48.3% | -24.4% | -33.4% | |
| Dec 27, 2021 | CYTK Cytokinetics Inc | Director | Sale+OE | 28,290 | $45.79 | $1,295,399.10 | -58.2% | -19.8% | -1.4% | |
| Nov 19, 2021 | CYTK Cytokinetics Inc | Director | Sale+OE | 29,032 | $41.21 | $1,196,275.17 | -58.9% | -13.8% | +0.7% | |
| Jul 19, 2021 | CYTK Cytokinetics Inc | Director | Sale+OE | 11,965 | $28.87 | $345,467.50 | -38.2% | +32.5% | +48.1% | |
| Apr 27, 2021 | CYTK Cytokinetics Inc | Director | Sale+OE | 9,739 | $27.76 | $270,322.50 | -84.1% | +5.4% | +29.6% | |
| Apr 26, 2021 | CYTK Cytokinetics Inc | Director | Sale+OE | 5,000 | $27.00 | $135,000.00 | -84.5% | +4.5% | +25.7% | |
| Apr 23, 2021 | CYTK Cytokinetics Inc | Director | Sale+OE | 5,000 | $26.50 | $132,500.00 | -84.5% | +13.6% | +35.6% | |
| Apr 15, 2021 | CYTK Cytokinetics Inc | Director | Sale+OE | 10,714 | $25.23 | $270,350.00 | -85.3% | -25.5% | +59.1% | |
| Apr 9, 2021 | CYTK Cytokinetics Inc | Director | Sale+OE | 27,582 | $23.93 | $659,990.00 | -83.3% | -18.3% | +72.6% | |
| Oct 5, 2020 | CYTK Cytokinetics Inc | Director | Sale+OE | 5,936 | $30.00 | $178,080.00 | -100% | - | - |